601.00
+6.50
+(1.09%)
At close: January 10 at 5:29:55 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
314,750.00
606,878.00
101,199.00
-143,427.00
-238,832.00
Investing Cash Flow
-11,869.00
-10,127.00
5,382.00
-4,943.00
-3,326.00
Financing Cash Flow
1,296,527.00
28,763.00
43,705.00
98,904.00
347,852.00
End Cash Position
2,753,262.00
1,189,840.00
565,539.00
411,575.00
461,793.00
Capital Expenditure
-11,869.00
-10,127.00
-1,905.00
-4,943.00
-3,326.00
Issuance of Capital Stock
1,307,289.00
32,692.00
58,492.00
106,046.00
352,634.00
Free Cash Flow
302,881.00
596,751.00
99,294.00
-148,370.00
-242,158.00
12/31/2020 - 12/3/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SQZB SQZ Biotechnologies Company
0.0300
0.00%
PILA.ST Pila Pharma AB (publ)
4.5700
-2.97%
BIOVIC-B.ST Biovica International AB (publ)
1.9400
+8.87%
ISOFOL.ST Isofol Medical AB (publ)
2.3600
-3.28%
ACE.ST Ascelia Pharma AB (publ)
2.9850
+10.15%
BINV.ST BioInvent International AB (publ)
31.00
-2.67%
5KW.F SkinBioTherapeutics plc
0.1720
+1.18%
7IZ.MU Ziccum AB
0.0298
-29.72%
HQ1.MU Oruka Therapeutics Inc. R
18.60
0.00%
ORN.F Oryzon Genomics S.A.
1.5020
+2.18%